Objective Bayes Factor Based Model Selection for Zero-Inflated Microbiome Count Data Under Jeffreys Prior

Microbiome omics data including 16S rRNA reveal intriguing dynamic associations between the human microbiome and various disease states. Drastic changes in microbiota can be associated with factors like diet, hormonal cycles, diseases, and medical interventions. Along with the identification of specific bacteria taxa associated with diseases, recent advancements give evidence that metabolism, genetics, and environmental factors can model these microbial effects. As a result, often the interest is to select an appropriate model to carry out the further analysis. Toward this end, we propose the Bayes factor approach for model selection based on negative binomial, Poisson, zero-inflated negative binomial, and zero-inflated Poisson models with non-informative Jeffreys prior. We find that both in simulation studies and real data analysis, our Bayes factor remarkably outperform traditional Akaike information criterion and Vuong’s test. A new R package BFZINBZIP has been introduced to carry out the simulation studies and real data analysis to facilitate Bayesian model selection based on the Bayes factor.

Authors

Institutions

Publication Details

Journal
Statistics in Biopharmaceutical Research
Published
2026-09-25
DOI
https://doi.org/10.1080/19466315.2026.2739408
Primary Topic
Bayesian Methods and Mixture Models
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Objective Bayes Factor Based Model Selection for Zero-Inflated Microbiome Count Data Under Jeffreys Prior

Arnab K. Maity, Paramahansa Pramanik
Statistics in Biopharmaceutical Research
Bayesian Methods and Mixture Models
article

Objective Bayes Factor Based Model Selection for Zero-Inflated Microbiome Count Data Under Jeffreys Prior

Arnab K. Maity, Paramahansa Pramanik
article en

Abstract

Microbiome omics data including 16S rRNA reveal intriguing dynamic associations between the human microbiome and various disease states. Drastic changes in microbiota can be associated with factors like diet, hormonal cycles, diseases, and medical interventions. Along with the identification of specific bacteria taxa associated with diseases, recent advancements give evidence that metabolism, genetics, and environmental factors can model these microbial effects. As a result, often the interest is to select an appropriate model to carry out the further analysis. Toward this end, we propose the Bayes factor approach for model selection based on negative binomial, Poisson, zero-inflated negative binomial, and zero-inflated Poisson models with non-informative Jeffreys prior. We find that both in simulation studies and real data analysis, our Bayes factor remarkably outperform traditional Akaike information criterion and Vuong’s test. A new R package BFZINBZIP has been introduced to carry out the simulation studies and real data analysis to facilitate Bayesian model selection based on the Bayes factor.

Statistics in Biopharmaceutical Research
Boehringer Ingelheim (Taiwan) (TW), University of South Alabama (US)
Openalex Percentile: Top 9%
Bayesian Methods and Mixture Models
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Objective Bayes Factor Based Model Selection for Zero-Inflated Microbiome Count Data Under Jeffreys Prior — Arnab K. Maity, Paramahansa Pramanik · Statistics in Biopharmaceutical Research (2026) | TGRS Research Map | TGRS